Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.

Saved in:

Bibliographic Details
Title:	Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.
Authors:	Gengwei Huo^1,2,3,4, Ying Song⁵, Peng Chen^1,2,3,4 chenpengdoc@sina.com
Source:	Journal of Gynecologic Oncology. Nov2024, Vol. 35 Issue 6, p1-11. 11p.
Database:	Academic Search Ultimate

Description
ISSN:	20050380
DOI:	10.3802/jgo.2024.35.e86